OTHER INFORMATION
−Removed: Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on May 24, 2023).
−Removed: Form of Warrant (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on May 24, 2023).
−Removed: Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.
−Removed: to the Company’s Current Report on Form 8-K filed on May 24, 2023).
−Removed: Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 24, 2023).
+Added: Second Amendment to the Dermata Therapeutics, Inc.
+Added: 2021 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 3, 2023).
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a).
13 unchanged sentences
Dermata Therapeutics, Inc.
−Removed: August 10, 2023
+Added: November 9, 2023
/s/ Gerald T.
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.